Why Not Canada for Your Phase 3 Global Trial Expansion?
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
2020 a Year Like No Other: What it Takes to Keep Ahead of Rapid Change
This time last year none of us imagined we were about to go through a year like no other, and…
Continued Importance of CRAs Supporting Role for Patient Centric Trials
The COVID-19 world-wide pandemic has forced the clinical trial industry to make rapid changes in order to continue protecting participant…
CRAs Play a Supporting Role in Patient-Centric Trials
There is an ever-present desire in the clinical trial industry to practice ‘patient-centricity’. This practice is featured predominantly during the…
Overcome Oncology Clinical Trial Obstacles – 2019 Real World Evidence for 2020 and Beyond
Overall the clinical trial market is growing at a robust pace that is expected to continue into 2024, owing to…
Going Above-and-Beyond – What Can Your Specialized Oncology CRO Do for You?
Clinical research is a growing and fascinating field marked by increasing complexity and competitive surroundings. CROs can help their Sponsors…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
7 Tips for Efficient Oncology Study Start-up
7 Tips for efficient study start-up: No.1) Involve Canadian oncologists early on and gather country-specific insight regarding possible enrollment…
How Does Your CRO’s Feasibility Process Contribute to Your Clinical Trial Success?
In clinical research, the process of finding and selecting sites is essential to the success of a study, as it…
Canadian Know-How: Successfully Navigating a Centralized Framework for Oncology Clinical Trial Ethical Review
Now more than ever, time is of the essence when it comes to oncology clinical trial start-up and execution. The…